Idera Pharmaceuticals, Inc. financial reports, Idera Pharmaceuticals, Inc. annual revenue in 2024. When does Idera Pharmaceuticals, Inc. report revenue?
Idera Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Idera Pharmaceuticals, Inc. revenue for the past few reporting periods. Net revenue Idera Pharmaceuticals, Inc. is now 0 $. Information about net revenue is taken from open sources. Here are the main financial indicators of Idera Pharmaceuticals, Inc.. The financial graph of Idera Pharmaceuticals, Inc. displays the online status: net income, net revenue, total assets. Information on Idera Pharmaceuticals, Inc. net income on the chart on this page is drawn in blue bars. The value of the "total revenue of Idera Pharmaceuticals, Inc." on the chart is marked in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-
115 738 000 $
-
31/12/2020
0 $
-100 % ↓
-76 701 000 $
-
30/09/2020
0 $
-
-20 552 000 $
-
30/06/2020
0 $
-100 % ↓
-24 226 000 $
-
30/09/2019
0 $
-
-11 133 000 $
-
30/06/2019
1 448 000 $
-
-11 176 000 $
-
31/03/2019
0 $
-
-10 974 000 $
-
31/12/2018
99 000 $
-
-12 150 000 $
-
30/09/2018
145 000 $
-
-11 605 000 $
-
30/06/2018
163 000 $
-
-16 031 000 $
-
31/03/2018
255 000 $
-
-20 095 000 $
-
31/12/2017
173 000 $
-
-14 926 000 $
-
30/09/2017
164 000 $
-
-14 530 000 $
-
30/06/2017
187 000 $
-
-21 471 000 $
-
Show:
to
Idera Pharmaceuticals, Inc. financial report charts
The dates of the latest financial statements of Idera Pharmaceuticals, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Idera Pharmaceuticals, Inc. is available online for such a date - 31/03/2021. Gross profit Idera Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Idera Pharmaceuticals, Inc. is -3 896 000 $
Idera Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Idera Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Idera Pharmaceuticals, Inc. is 3 896 000 $ Operating income Idera Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Idera Pharmaceuticals, Inc. is -10 027 000 $ Net income Idera Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Idera Pharmaceuticals, Inc. is 115 738 000 $
Current assets Idera Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Idera Pharmaceuticals, Inc. is 47 018 000 $ Total assets Idera Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Idera Pharmaceuticals, Inc. is 48 008 000 $ Current cash Idera Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Idera Pharmaceuticals, Inc. is 44 541 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-3 896 000 $
-3 327 000 $
-2 818 000 $
-5 379 000 $
-6 208 000 $
-6 245 000 $
-5 452 000 $
-6 428 000 $
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
3 896 000 $
3 327 000 $
2 818 000 $
5 379 000 $
6 208 000 $
7 693 000 $
5 452 000 $
6 527 000 $
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
1 448 000 $
-
99 000 $
145 000 $
163 000 $
255 000 $
173 000 $
164 000 $
187 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
1 448 000 $
-
99 000 $
145 000 $
163 000 $
255 000 $
173 000 $
164 000 $
187 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-10 027 000 $
-8 040 000 $
-7 484 000 $
-8 011 000 $
-11 382 000 $
-11 471 000 $
-11 245 000 $
-12 401 000 $
-12 699 000 $
-16 300 000 $
-20 280 000 $
-15 020 000 $
-14 667 000 $
-21 592 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
115 738 000 $
-76 701 000 $
-20 552 000 $
-24 226 000 $
-11 133 000 $
-11 176 000 $
-10 974 000 $
-12 150 000 $
-11 605 000 $
-16 031 000 $
-20 095 000 $
-14 926 000 $
-14 530 000 $
-21 471 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
2 975 000 $
1 790 000 $
1 948 000 $
1 948 000 $
2 151 000 $
2 331 000 $
2 650 000 $
2 402 000 $
8 860 000 $
10 880 000 $
13 556 000 $
10 365 000 $
10 912 000 $
17 891 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
10 027 000 $
8 040 000 $
7 484 000 $
8 011 000 $
11 382 000 $
12 919 000 $
11 245 000 $
12 500 000 $
12 844 000 $
16 463 000 $
20 535 000 $
15 193 000 $
14 831 000 $
21 779 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
47 018 000 $
41 355 000 $
31 239 000 $
33 687 000 $
45 074 000 $
53 940 000 $
61 600 000 $
72 807 000 $
84 980 000 $
97 969 000 $
110 110 000 $
116 621 000 $
69 010 000 $
81 444 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
48 008 000 $
42 399 000 $
32 338 000 $
34 785 000 $
45 392 000 $
54 332 000 $
62 001 000 $
73 023 000 $
85 230 000 $
99 514 000 $
111 751 000 $
118 417 000 $
70 749 000 $
83 373 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
44 541 000 $
33 229 000 $
22 332 000 $
27 810 000 $
32 611 000 $
39 884 000 $
24 198 000 $
71 431 000 $
82 773 000 $
94 357 000 $
107 770 000 $
112 629 000 $
63 941 000 $
74 659 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
7 766 000 $
6 585 000 $
6 276 000 $
9 018 000 $
-
-
131 000 $
209 000 $
285 000 $
309 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
82 462 000 $
94 046 000 $
107 459 000 $
112 629 000 $
65 341 000 $
77 235 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
7 766 000 $
6 597 000 $
6 329 000 $
9 029 000 $
-
-
-
-
-
359 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
17.11 %
12.14 %
10.21 %
12.36 %
-
-
-
-
-
0.43 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
42 304 000 $
-91 172 000 $
-32 435 000 $
-17 691 000 $
37 626 000 $
47 735 000 $
55 672 000 $
63 994 000 $
74 866 000 $
85 066 000 $
98 884 000 $
107 695 000 $
62 080 000 $
74 872 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-10 841 000 $
-9 973 000 $
-13 357 000 $
-11 472 000 $
-11 792 000 $
-13 905 000 $
-14 747 000 $
-11 500 000 $
-11 884 000 $
-14 229 000 $
Last revenue report of Idera Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Idera Pharmaceuticals, Inc. was 0 US dollar and changed by -100% since last year. Net income in Idera Pharmaceuticals, Inc. was 115 738 000 $ in last quartal, net income changes to 0%.
Idera Pharmaceuticals, Inc. stocks data
IDRA stock price
Idera Pharmaceuticals, Inc. stock price today, IDRA stock quote.
